Filing Details
- Accession Number:
- 0001179110-20-003841
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-17 17:46:13
- Reporting Period:
- 2020-03-16
- Accepted Time:
- 2020-03-17 17:46:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1479419 | Kala Pharmaceuticals Inc. | KALA | Pharmaceutical Preparations (2834) | 270604595 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1605767 | Todd Bazemore | C/O Kala Pharmaceuticals, Inc. 490 Arsenal Way, Suite 120 Watertown MA 02472 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-16 | 10,000 | $5.75 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
